Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612 | ISIN: INE873D01024 | Industry: Pharmaceuticals
| Momentum Trap
285.0500 3.50 (1.24%)
NSE Jun 20, 2025 15:31 PM
Volume: 28,518
 

285.05
1.24%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 15.2% YoY to | 257.4 crore (I-direct estimate: | 269.4 crore) mainly due to 18.4% YoY growth in export formulations to | 92.3 crore (I-direct estimates: | 115.6 crore). Domestic formulations grew 12.7% to | 142.1 crore (I-direct estimate: | 130.6 crore) EBITDA margins declined 238 bps YoY to 16.2% (I-direct estimate of 17.9%) mainly on account of an increase in employee expenditure...
Indoco Remedies Ltd. has gained 21.21% in the last 3 Months
More from Indoco Remedies Ltd.
Recommended